Rosuvastatin for cholesterol lowering was associated with slightly greater risks for kidney harm than atorvastatin, risks that were greater at higher-dose levels, in a large retrospective cohort study ...

Barcelona, Spain - The addition of ezetimibe (Zetia, Merck/Schering-Plough Pharmaceuticals) to statin therapy with rosuvastatin (Crestor, AstraZeneca) reduced LDL-cholesterol levels by 70%, allowing ...

Large observational studies, small prospective studies and post-hoc analyses of randomised clinical trials have suggested that statins could be beneficial in patients with chronic heart failure.

Rosuvastatin is prescribed to people with high cholesterol ...